Indeed, our recent studies of quantitative immunocytochemistry of VEGF-C protein expression in human breast cancer cells in situ revealed no significant difference of expression levels between lymph node positive and negative specimens, suggesting additional lymphangiogenesis-independent role(s) of VEGF-C (Lala et al, 2007). Here, VEGFC is linked to breast carcinoma.